Medical Trial: Appraising Medical Trial Experiences of Rheumatoid Arthritis Patients
NCT05398471 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2024-01-02
Summary
Historically, participation in clinical trials has been highly skewed towards specific demographic groups. However, research identifying which trial attributes impact participation, in either positive or negative ways, is limited. This study invites participants to record a wide range of data on their clinical trial experience, with the goal being to identify factors which persistently limit patients' ability to participate in, or complete, a trial in which they were initially interested. This data will be analyzed through a range of demographic lenses, in hopes of discovering patterns which might improve the experience of future rheumatoid arthritis patients.
Conditions
Sponsors & Collaborators
-
Power Life Sciences Inc.
lead INDUSTRY
Principal Investigators
-
Michael B Gill · Power Life Sciences Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-08-31
- Primary Completion
- 2025-08-31
- Completion
- 2026-08-31
Countries
- United States
Study Locations
More Related Trials
-
Study to Assess the Safety and Tolerability of MEDI5117 in Rheumatoid Arthritis Patients
NCT01559103 ·Status: TERMINATED ·Phase: PHASE1
-
Methotrexate Use Improvement in Rheumatoid Arthritis Using Biomarker Feedback
NCT03913728 ·Status: COMPLETED ·Phase: NA
-
Rheumatoid Arthritis Satisfaction Outcome Research
NCT03703817 ·Status: COMPLETED
-
Effects of MEDI-522 On Disease Activity and Progression of Joint Damage in Patients With Active Rheumatoid Arthritis Suboptimally Responding to Methotrexate
NCT00069017 ·Status: COMPLETED ·Phase: PHASE2
-
Atacicept in Anti-Tumor Necrosis Factor Alpha-naïve Subjects With Rheumatoid Arthritis (AUGUST II)
NCT00595413 ·Status: COMPLETED ·Phase: PHASE2
-
A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate
NCT00847613 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
NCT01225393 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid Arthritis
NCT00959036 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate
NCT00235859 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid Arthritis
NCT02919761 ·Status: COMPLETED ·Phase: PHASE4
-
Objective Study in Rheumatoid Arthritis
NCT00451971 ·Status: COMPLETED ·Phase: PHASE4
-
Dose Optimisation Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate
NCT00854685 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis
NCT00853385 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of a Novel Investigational Drug in Rheumatoid Arthritis Patients (MK-0873-012)(COMPLETED)
NCT00132769 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of Immunological and Pharmacological Factors for Response to Adalimumab in Rheumatoid Arthritis
NCT03110094 ·Status: COMPLETED ·Phase: NA
-
A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of Action
NCT01638715 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics
NCT01636817 ·Status: TERMINATED ·Phase: PHASE2
-
Factors Associated With Biologic DMARD Switching
NCT02346942 ·Status: COMPLETED
-
Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients
NCT00280917 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment Adherence to Injectable Methotrexate in Rheumatoid Arthritis
NCT02897817 ·Status: COMPLETED
-
Quality of Life Study With Adalimumab in Rheumatoid Arthritis
NCT00234936 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Tolerability and Safety Study in Rheumatoid Arthritis (0812-008)
NCT00542022 ·Status: COMPLETED ·Phase: PHASE2
-
Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) Treatment
NCT02873936 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial to Evaluate the Safety, Tolerability, and Efficacy of MK-8457 in Participants With Rheumatoid Arthritis (MK-8457-010)
NCT01651936 ·Status: TERMINATED ·Phase: PHASE2
-
A Study in Normal Healthy People, Testing Different Versions of a Pill That Will be Used to Treat Rheumatoid Arthritis.
NCT00838058 ·Status: COMPLETED ·Phase: PHASE1